U.S. Announces Negotiated Prices for 15 Drugs Under Medicarenews2025-11-26T03:09:55+00:00November 26th, 2025|The New York Times|
Postpartum Prescription of GLP-1 Drugs Has Increased Sharply, Study Findsnews2025-11-25T20:54:17+00:00November 25th, 2025|The New York Times|
RFK Jr. Walks a Tightrope on Trump Deal for Obesity Drugsnews2025-11-14T10:02:07+00:00November 14th, 2025|The New York Times|
Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Dealnews2025-11-08T12:38:25+00:00November 8th, 2025|The New York Times|
Costco to Sell Ozempic and Wegovy, Weight-Loss Wonder Drugsnews2025-10-05T19:47:27+00:00October 5th, 2025|The New York Times|
How Private Equity Oversees the Ethics of Drug Researchnews2025-10-04T09:00:13+00:00October 4th, 2025|The New York Times|
How Ozempic Maker Novo Nordisk Lost Its Shinenews2025-08-07T13:33:20+00:00August 7th, 2025|The New York Times|
Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warningnews2025-07-29T17:51:03+00:00July 29th, 2025|The New York Times|
Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugsnews2025-05-16T16:17:20+00:00May 16th, 2025|The New York Times|
What to Know About Eli Lilly’s Daily Pill for Weight Lossnews2025-04-17T21:24:51+00:00April 17th, 2025|The New York Times|
